Japanese Pharmaceuticals & Biotech Potentially Undervalued Companies

Otsuka Holdings

Market Cap: JP¥3.6t

Engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide.

Towa Pharmaceutical

Market Cap: JP¥152.6b

Researches, develops, produces, and sells ethical drugs, active pharmaceutical ingredients, and intermediates in Japan.

Daiichi Sankyo Company

Market Cap: JP¥7.3t

Manufactures and sells pharmaceutical products in Japan, North America, Europe, and internationally.

Hisamitsu Pharmaceutical

Market Cap: JP¥300.0b

Manufactures and sells pharmaceuticals in Japan.

Nippon Shinyaku

Market Cap: JP¥232.5b

Manufactures and sells pharmaceuticals and foodstuffs in Japan and internationally.

Santen Pharmaceutical

Market Cap: JP¥540.4b

Engages in the research and development, manufacture, and marketing of pharmaceuticals and medical devices in Japan and internationally.

Tsumura

Market Cap: JP¥257.1b

Manufactures and sells pharmaceutical products from crude drugs derived from plants and other natural products in Japan and internationally.

PeptiDream

Market Cap: JP¥219.6b

A biopharmaceutical company, engages in the discovery and development of constrained peptides, small molecules, and peptide-drug conjugate therapeutics.

Shionogi

Market Cap: JP¥2.0t

Engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan.

Daito PharmaceuticalLtd

Market Cap: JP¥59.6b

Manufactures and sells pharmaceutical products worldwide.

Fuji Pharma

Market Cap: JP¥31.6b

Engages in the research and development, manufacture, and marketing of pharmaceutical products in Japan and internationally.

Zeria Pharmaceutical

Market Cap: JP¥95.4b

Manufactures, sells, imports, and exports pharmaceuticals, non-pharmaceutical products, veterinary pharmaceuticals, agricultural chemicals, industrial chemicals, and reagents in Japan and internationally.

Kidswell Bio

Market Cap: JP¥8.4b

Develops pharmaceuticals for the treatment of rare and intractable diseases in Japan.

Sumitomo Pharma

Market Cap: JP¥302.3b

Engages in the manufacture and sale of pharmaceuticals, food ingredients and additives, veterinary medicines, and others in Japan, North America, China, and internationally.

Human Metabolome Technologies

Market Cap: JP¥4.5b

Human Metabolome Technologies, Inc., biotechnology company, develops metabolomics technologies and solutions for drug discovery, diagnosis, and food production in Japan.

Kissei Pharmaceutical

Market Cap: JP¥162.2b

Researches, develops, manufactures, and sells pharmaceutical products primarily in Japan.

Ono Pharmaceutical

Market Cap: JP¥726.3b

Produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide.

WDB coco

Market Cap: JP¥7.0b

Provides contract services to pharmaceutical companies in Japan.

Japan Tissue Engineering

Market Cap: JP¥23.6b

Engages in the regenerative medicine business in Japan.

Kohjin Bio

Market Cap: JP¥8.4b

Manufactures and sells animal blood, sera, tissue culture media, agar media for microorganism tests, in-vitro diagnostic agents, and cosmetics.

Astena Holdings

Market Cap: JP¥19.2b

Manufactures and sells medicine-related products in Japan.

ASKA Pharmaceutical HoldingsLtd

Market Cap: JP¥65.5b

Through its subsidiaries, engages in the pharmaceutical, animal health, and hormone testing businesses in Japan.

Sawai Group Holdings

Market Cap: JP¥205.9b

Together with subsidiaries, engages in the research and development, manufacturing, and marketing of generic pharmaceuticals.

Shin Nippon Biomedical Laboratories

Market Cap: JP¥54.8b

A contract research organization, engages in the transactional research and medipolis businesses in Japan and internationally.

Fuso Pharmaceutical IndustriesLtd

Market Cap: JP¥18.6b

Manufactures and sells pharmaceuticals and medical equipment in Japan.

Chugai Pharmaceutical

Market Cap: JP¥12.3t

Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.

Kyowa Kirin

Market Cap: JP¥1.2t

Engages in the research, development, manufacturing, marketing, and import/export of pharmaceuticals for oncology, nephrology, central nervous system, and immunology therapeutic areas in Japan, the United States, rest of the Americas, Europe, Asia, and internationally.

Immuno-Biological Laboratories

Market Cap: JP¥5.1b

Engages in the research, development, manufacturing, and supply of various immunological research reagents worldwide.